Thalia Therapeutics Plc (AIM:THAT)

Thalia Therapeutics Revenue

In the year 2025, Thalia Therapeutics had annual revenue of 7.26K GBP, down -0.25%. Thalia Therapeutics had revenue of 3.57K in the half year ending December 31, 2025, with 83.00% growth.

• Revenue: 7.26K
• Revenue Growth: -0.25%
• P/S Ratio: 744.74
• Revenue / Employee: 2.42K
• Employees: 3
• Market Cap: 5.41M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.26K	-18.00	-0.25%
Dec 31, 2024	7.28K	5.33K	272.86%
Dec 31, 2023	1.95K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 3, 2026

Data Sources Report a data error